These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1672646

  • 21. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients.
    Wang ZQ, Orlikowsky T, Dudhane A, Mittler R, Blum M, Lacy E, Riethmüller G, Hoffmann MK.
    Eur J Immunol; 1994 Jul; 24(7):1553-7. PubMed ID: 7913036
    [Abstract] [Full Text] [Related]

  • 22. A defined conformational epitope from the C4 domain of HIV type 1 glycoprotein 120: anti-cyclic C4 antibodies from HIV-positive donors magnify glycoprotein 120 suppression of interleukin 2 produced by T cells.
    Robey FA, Robert-Guroff M.
    AIDS Res Hum Retroviruses; 2001 Apr 10; 17(6):533-41. PubMed ID: 11350667
    [Abstract] [Full Text] [Related]

  • 23. Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity.
    Wang H, Müller S, Zolla-Pazner S, Köhler H.
    Eur J Immunol; 1992 Jul 10; 22(7):1749-55. PubMed ID: 1378015
    [Abstract] [Full Text] [Related]

  • 24. Biological properties of a CD4 immunoadhesin.
    Byrn RA, Mordenti J, Lucas C, Smith D, Marsters SA, Johnson JS, Cossum P, Chamow SM, Wurm FM, Gregory T, Groopman JE, Capon DJ.
    Nature; 1990 Apr 12; 344(6267):667-70. PubMed ID: 1970124
    [Abstract] [Full Text] [Related]

  • 25. Anti-idiotypic antibodies against anti-CD4 antibodies MT151 and OKT4A.
    Liang SH, Rieber P, Prewett M, Riethmüller G, Pletcher C, Hoxie J, Koprowski H, Herlyn D.
    Viral Immunol; 1991 Apr 12; 4(2):83-90. PubMed ID: 1722100
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
    Furci L, Beretta A, Siccardi A, Lazzarin A, Confetti C, Magnani Z, Scarpellini P, Lopalco L, Burastero SE.
    AIDS Res Hum Retroviruses; 1997 Nov 20; 13(17):1461-9. PubMed ID: 9390745
    [Abstract] [Full Text] [Related]

  • 31. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
    Hioe CE, Jones GJ, Rees AD, Ratto-Kim S, Birx D, Münz C, Gorny MK, Tuen M, Zolla-Pazner S.
    AIDS Res Hum Retroviruses; 2000 Jun 10; 16(9):893-905. PubMed ID: 10875615
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia.
    Karpatkin S, Nardi MA, Kouri YH.
    Proc Natl Acad Sci U S A; 1992 Feb 15; 89(4):1487-91. PubMed ID: 1741404
    [Abstract] [Full Text] [Related]

  • 34. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.
    Chamow SM, Zhang D, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP.
    J Hematother; 1995 Oct 15; 4(5):439-46. PubMed ID: 8581382
    [Abstract] [Full Text] [Related]

  • 35. Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle.
    Thomas EK, Connelly RJ, Pennathur S, Dubrovsky L, Haffar OK, Bukrinsky MI.
    Viral Immunol; 1996 Oct 15; 9(2):73-87. PubMed ID: 8822624
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
    Chien PC, Chen D, Chen PD, Tuen M, Cohen S, Migueles SA, Connors M, Rosenberg E, Malhotra U, Gonzalez C, Hioe CE.
    J Infect Dis; 2004 Mar 01; 189(5):852-61. PubMed ID: 14976603
    [Abstract] [Full Text] [Related]

  • 39. [Peptides from the principal neutralizing and CD4-binding domain: similar immunoreactive properties and structure pattern].
    Meshcheriakova DV, Andreev SM, Sidorova MV, Vafina MG, Az'muko AA, Petrukhina AO, Khaitov RM.
    Vestn Ross Akad Med Nauk; 1992 Mar 01; (9-10):47-52. PubMed ID: 1283721
    [Abstract] [Full Text] [Related]

  • 40. High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression.
    Chien PC, Cohen S, Kleeberger C, Giorgi J, Phair J, Zolla-Pazner S, Hioe CE.
    J Infect Dis; 2002 Jul 15; 186(2):205-13. PubMed ID: 12134256
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.